About BridgeBio Oncology Therapeutics (BBOT)
BridgeBio Oncology Therapeutics (BBOT) is a publicly traded company in the Healthcare sector, specifically in the Biotechnology industry. View real-time stock data, AI analysis, options flow, and convergence signals for BBOT on iGotFomo.
BBOT Key Statistics
| Current Price | $8.40 | Market Cap | $672 million |
|---|---|---|---|
| Daily Change | -5.14% | Volume | 277K |
| 52-Week High | $14.87 | 52-Week Low | $8.08 |
| P/E Ratio (TTM) | 151.16 | Forward P/E | -4.10 |
| Sector | Healthcare | Industry | Biotechnology |
Frequently Asked Questions About BBOT
- What is BridgeBio Oncology Therapeutics (BBOT)?
- BridgeBio Oncology Therapeutics (BBOT) is a publicly traded company in the Healthcare sector, operating in the Biotechnology industry.
- What is the current BBOT stock price?
- As of the latest trading session, BBOT trades at $8.40 per share, with a daily change of -5.14%.
- What is BBOT's market capitalization?
- BridgeBio Oncology Therapeutics has a market capitalization of $672 million, making it a small-cap stock.
- What sector does BBOT belong to?
- BridgeBio Oncology Therapeutics operates in the Healthcare sector, specifically in the Biotechnology industry. View all Healthcare stocks.